[Legal Talk] "Korean Biopharma Licensing" (partnering with Korean Pharmaceutical and Biopharma Manufacturers Association)

-

 



Introducing my latest video partnering with the ‘Korean Pharmaceutical and Bio-pharma Manufacturers Association’ on 'Useful licensing tips for Biopharma companies'.

Youtube video link: https://youtu.be/SuscTNYxBRI?si=7NCsJG38FC05DPLm


Location: Seoul, South Korea

Comments

Post a Comment

Popular posts from this blog

South Korea's Telemedicine Industry, where are we at?

-
Image
The Korean telemedicine industry has been experiencing significant growth and transformation, spurred by advancements in technology and changes in healthcare delivery models. Although so far, South Korea's regulatory environment has not been so friendly for the telemedicine industry, limiting the scope of telemedicine services, there have been many efforts to expand telemedicine regulations to accommodate technological advancements and changing healthcare needs. During the COVID pandemic, this unprecedented experience has accelerated the adoption of telemedicine globally, including in South Korea. As social distancing measures and lockdowns restricted in-person healthcare visits, telemedicine emerged as a crucial alternative for patients to receive medical advice and treatment while minimizing the risk of virus transmission. As a result, the South Korean government has recognized the potential benefits of telemedicine in improving healthcare accessibility, especially in remote area...
Read more

Amendment of the 'Act On The Safety Of And Support For Advanced Regenerative Medicine And Advanced Biological Products' welcomed by the industry

-
Image
On the first day of this month, the Ministry of Food and Drug Safety and the biotech industry welcomed the acceptance of the bill adding 'Regenerative Medical Institutions' as human cell management by the National Assembly, amending the 'Act On The Safety Of And Support For Advanced Regenerative Medicine And Advanced Biological Products'.  Human Cell Management businesses are operators who collect, import, inspect, process, and supply human cells, which have been mostly in-house product manufacturers or the blood banks. Now that this amendment has been approved, advanced regenerative medical institutions equipped with facilities, equipment, and personnel similar to the standards for human cell management, shall also be recognized as subjects for permits for the management of human cells. This means that advanced regenerative medical institutions can supply raw materials by performing minimal procedures such as simple isolation, washing, freezing, and thawing of cells ob...
Read more